MedPath

Exparel v Dexamethasone in RCR

Phase 4
Conditions
Rotator Cuff Tears
Postoperative Pain
Interventions
Registration Number
NCT06575010
Lead Sponsor
Rothman Institute Orthopaedics
Brief Summary

Effective and safe control of pain after shoulder surgery is an important component of the post-surgical process. Patients who are comfortable in the early period after surgery are more satisfied with their experience and are better able to participate in rehabilitation exercises during their stay in the hospital. As surgeons and health care systems in the United States find themselves in the middle of an opioid epidemic, it is necessary to discover different options to provide patients pain relief that are both effective and safe in an effort to decrease the amount of pain medication used.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
126
Inclusion Criteria
  • Participants having a primary rotator cuff repair
  • Age 18 and older
  • English speaking
  • Ability to complete surveys by phone or in person
  • Ability to provide informed consent
Exclusion Criteria
  • Revision rotator cuff repair (RCR) cases
  • Participants having an open RCR
  • Allergies and/or medical contra-indications to study medications
  • Non-English speakers
  • Participants who are pregnant, plan to become pregnant and do not utilize adequate contraceptive means, or are currently breastfeeding (all patients who have the potential to be pregnant are administered a urine beta-HCG pregnancy test, with suspected false-positive or equivocal urine pregnancy tests followed by a more specific serum pregnancy test)
  • Rotator cuff repair needing Graft Augmentation
  • Known alcohol or narcotic abuse history
  • Existing contract with a pain specialist due to underlying preoperative pain syndrome
  • Preoperative opioid use within the 3 months prior to surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2: Shoulder Block using Exparel + DexamethasoneDexamethasoneParticipants having rotator cuff repair surgery will receive Liposomal bupivacaine (Exparel) + Dexamethasone + bupivacaine given in their shoulder block before surgery.
Group 2: Shoulder Block using Exparel + DexamethasoneBupivacaine Hcl 0.5% InjParticipants having rotator cuff repair surgery will receive Liposomal bupivacaine (Exparel) + Dexamethasone + bupivacaine given in their shoulder block before surgery.
Group 1: Shoulder Block using ExparelBupivacaine Hcl 0.5% InjParticipants having rotator cuff repair surgery will receive Liposomal bupivacaine (Exparel) + bupivacaine given in their shoulder block before surgery.
Group 2: Shoulder Block using Exparel + DexamethasoneLiposomal bupivacaineParticipants having rotator cuff repair surgery will receive Liposomal bupivacaine (Exparel) + Dexamethasone + bupivacaine given in their shoulder block before surgery.
Group 1: Shoulder Block using ExparelLiposomal bupivacaineParticipants having rotator cuff repair surgery will receive Liposomal bupivacaine (Exparel) + bupivacaine given in their shoulder block before surgery.
Primary Outcome Measures
NameTimeMethod
Postoperative narcotic medication use14 days

Participants will be asked to record the amount of medication they take to control pain after surgery

Postoperative pain levels14 days

This will be measured by providing participants the visual analog scale (VAS) questionnaire as well as a postoperative pain recording diary to complete after surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rothman Orthopaedic Institute

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath